Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Joshua N. Kellner, Eveline M. Delemarre, Eric Yvon, Stefan Nierkens, Jaap J. Boelens, Ian McNiece, Amanda Olson, Yago Nieto, Stefan Ciurea, Uday Popat, Sairah Ahmed, Richard Champlin, Jennifer Ramos, Mitsutaka Nishimoto, Hongbing Ma, Zeng Ke, Peter Thall, Joseph D. Khoury, Robert Negrin, Borje Andersson, Simrit Parmar
Published Nov 2, 2018 · Vol. 9, No. 86 · pp. 35611-35622
Qingyan Cui, Frank Vari, Alexandre S. Cristino, Carlos Salomon, Gregory E. Rice, Muhammed B. Sabdia, Dominic Guanzon, Carlos Palma, Marina Mathew, Dipti Talaulikar, Sanjiv Jain, Erica Han, Mark S. Hertzberg, Clare Gould, Pauline Crooks, Gayathri Thillaiyampalam, Colm Keane, Maher K. Gandhi
Published Oct 5, 2018 · Vol. 9, No. 78 · pp. 34644-34657
